🔎 Trials Near Me

Home › Kanser sa Dugo › District of Columbia › Washington

Pag-aaral pangklinika para sa Kanser sa Dugo sa Washington, DC

19 pag-aaral para sa Kanser sa Dugo ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Washington (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Nagre-recruitPhase 1
  • MedStar Georgetown University Hospital, Washington D.C.
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT03816345

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Nagre-recruitPhase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06904066

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

Nagre-recruitObservasyonal na pag-aaral
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 18 hanggang 110 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05724121

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Walter Reed National Military Medical Center, Bethesda · 7 mi ang layo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT05470491

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Nagre-recruitPhase 3
  • American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07648264

Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

Nagre-recruitPhase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07162038

Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05327023

Longitudinal Studies of Patient With FPDMM

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
1 Day – 100 Years · Lahat ng kasarian · Na-update Set 11, 2026 · NCT03854318

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 12 hanggang 120 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT05436418

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Nagre-recruitObservasyonal na pag-aaral
  • The Center for Cancer and Blood Disorders, Bethesda · 7 mi ang layo
Edad 0 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07154823

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Nagre-recruitPhase 1
  • Childrens National Medical Center, Washington D.C.
6 Months – 80 Years · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT02203903

Mosaic Trial for Stem Cell Transplant Recipients

Nagre-recruit
  • Georgetown University School of Medicine, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06960993

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Nagre-recruitObservasyonal na pag-aaral
  • Children's National Medical Center, Washington D.C.
  • Nih/Niaid, Bethesda · 7 mi ang layo
  • Nih/Nhlbi, Bethesda · 7 mi ang layo
Lahat ng edad · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Nagre-recruitPhase 1/2
  • The Center for Cancer and Blood Disorders (CCBD), Bethesda · 7 mi ang layo
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT04068597

Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 12 hanggang 85 · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT04959175

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Nagre-recruitObservasyonal na pag-aaral
  • George Washington University, Washington D.C.
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT05663502

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
  • National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update May 27, 2026 · NCT06856226

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Nagre-recruitPhase 1
  • Children's National Medical Center, Washington D.C.
  • National Cancer Institute, Pediatric Oncology Branch, Bethesda · 7 mi ang layo
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Dis 6, 2024 · NCT05476770

Pag-aaral para sa Kanser sa Dugo sa ibang lungsod

Iba pang pag-aaral sa Washington

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.